Clinical Investigator
Daiana Licu, MD
Merck Serono International SA
Total Trials
1
As PI
0
Completed
1
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 31
Trial Status
Completed1
Role Distribution
Other Roles1
Activity Timeline
Clinical Trials (1)
Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis
Moderate to Severe Psoriasis
Studydirector
Research Network
Collaboration Network
1 collaborators·0 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Merck Serono International SA
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
4 similar investigators found
John Koo, MD
UCSF Psoriasis and Skin Treatment Center, Department of Dermatology, University of California, San Francisco
2 trials
Shared therapeutic areas:
Moderate to Severe Psoriasis
Similarity Score30%
Patrick Natta, M.D.
Sponsor GmbH
1 trials
Shared therapeutic areas:
Moderate to Severe Psoriasis
Worked with same sponsors:
Merck KGaA, Darmstadt, Germany
Similarity Score30%
ANDREA PESERICO, PROF
University of Padova
1 trials
Shared therapeutic areas:
Moderate to Severe Psoriasis
Similarity Score30%
Manuel Uribe, MD
AbbVie
1 trials
Shared therapeutic areas:
Moderate to Severe Psoriasis
Similarity Score30%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis
Moderate to Severe Psoriasis
All 1 trials loaded